Related Experiment Video

Updated: May 10, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

A novel role of proteasomal β1 subunit in tumorigenesis

Fuqiang Yuan1, Yana Ma, Pan You

  • 1Xiamen University School of Life Sciences, Xiamen, Fujian, People's Republic of China.

Bioscience Reports
|June 4, 2013
PubMed

Insights

The proteasome subunit β1 is elevated in cancers and directly degrades the cell-cycle regulator p27Kip1, promoting tumor growth. This novel mechanism highlights β1 as a potential therapeutic target in tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • p27Kip1 is a crucial cell-cycle regulator primarily degraded via the ubiquitin-proteasome pathway.
  • The 20S proteasome's β1 subunit is involved in ubiquitinated protein degradation.
  • The role of the β1 subunit in cancer development is not fully understood.

Purpose of the Study:

  • To investigate the role of the proteasome β1 subunit in tumorigenesis.
  • To determine if the β1 subunit interacts with and degrades p27Kip1.
  • To explore the mechanism by which β1 influences cancer progression.

Main Methods:

  • Analysis of β1 subunit expression in oesophageal cancer tissues and ovarian cancer cell lines.
  • Assays to assess the impact of β1 on cell growth, migration, and colony formation.
  • Biochemical experiments to confirm direct binding and degradation of p27Kip1 by β1, including investigation of phosphorylation at Ser158.

Main Results:

  • The β1 subunit is upregulated in oesophageal cancer tissues and certain ovarian cancer cell lines.
  • Overexpression of β1 enhances cell proliferation, migration, and colony formation.
  • The β1 subunit directly binds to and degrades p27Kip1, with reduced phosphorylation at Ser158 enhancing this degradation.

Conclusions:

  • The proteasome β1 subunit plays a novel role in tumorigenesis by promoting cancer cell growth and migration.
  • β1-mediated degradation of p27Kip1 is a key mechanism contributing to its oncogenic function.
  • Targeting the β1 subunit or its interaction with p27Kip1 may offer a new therapeutic strategy for cancers.

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Assaying Proteasomal Degradation in a Cell-free System in Plants07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...